Dpp6 Antibody

What is DPP6 and what are its primary functions in neuronal systems?

DPP6 is a transmembrane protein that serves multiple critical functions in neuronal systems. Primarily, it promotes cell surface expression of potassium channel KCND2 and modulates its activity and gating characteristics . Unlike other dipeptidyl peptidases, DPP6 has no enzymatic aminopeptidase activity despite structural similarities to this enzyme family .

Recent research has revealed that DPP6 plays a crucial role in dendritic morphogenesis independent of its potassium channel regulatory function. Specifically, DPP6 regulates dendritic filopodia formation and stability during neuronal development, which impacts synaptogenesis and ultimately affects hippocampal synaptic function . This structural role begins early in development and persists into adulthood, suggesting DPP6's importance in proper circuit formation.

What applications are DPP6 antibodies validated for in neuroscience research?

DPP6 antibodies have been validated for several experimental applications in neuroscience research:

When selecting a DPP6 antibody, researchers should consider the specific application, species reactivity, and epitope recognition . For example, Abcam's antibody targets a recombinant fragment within human DPP6 amino acids 650 to C-terminus, which may affect its specificity for different DPP6 isoforms .

How should I optimize Western blot protocols for DPP6 detection?

Optimizing Western blot protocols for DPP6 detection requires careful consideration of several factors:

• Sample preparation: Brain tissue is the most common source for DPP6 detection. Use appropriate lysis buffers (e.g., 150 mM NaCl, 20 mM Tris-HCl, 1% NP40, 0.5% SDS with protease inhibitor mixture) .

• Gel selection: Use 3-8% Tris-acetate SDS polyacrylamide gels for better separation of the high molecular weight DPP6 protein .

• Expected molecular weight: Prepare to detect bands at approximately 98-100 kDa (observed molecular weight) and possibly at 155 kDa . Multiple bands may represent different isoforms or post-translational modifications.

• Antibody dilution: Start with 1:500-1:2000 dilution for primary antibody incubation and optimize as needed .

• Detection system: Fluorescent secondary antibodies (e.g., Alexa Fluor 680 or 800) provide quantifiable results with systems like the Odyssey infrared imaging system .

Always include appropriate positive controls (brain tissue lysates) and negative controls to validate specificity.

How can I investigate DPP6's role in dendritic morphogenesis using antibody-based approaches?

Investigating DPP6's role in dendritic morphogenesis requires a multifaceted approach combining antibody-based techniques with molecular and cellular methods:

• Immunocytochemistry in neuronal cultures: Use DPP6 antibodies to examine localization in dendritic filopodia and spines. Co-label with MAP2 to highlight dendritic arbors and phalloidin to visualize actin-based protrusions .

• Knockdown and rescue experiments: Combine DPP6 knockdown (using siRNA) with immunostaining to assess changes in filopodia density. For rescue experiments, express GFP-tagged DPP6 in DPP6-KO neurons and measure filopodia formation .

• Live imaging approaches: Transfect neurons with fluorescently-labeled DPP6 and perform time-lapse imaging to track filopodia formation and stability over time. This approach revealed that DPP6-KO neurons produce approximately 60% fewer filopodia than wild-type neurons and that existing filopodia in DPP6-KO neurons are less stable .

• Synaptogenesis assessment: Immunostain neurons for synaptophysin (presynaptic marker) and PSD-95 (postsynaptic marker). Count overlapping puncta as synapses to quantify the effect of DPP6 on synapse formation .

These methods have demonstrated that DPP6 plays a critical role in both initiating and stabilizing dendritic filopodia, which impacts subsequent synapse formation and dendritic arborization.

What are the optimal approaches for studying DPP6 protein interactions?

To study DPP6 protein interactions, co-immunoprecipitation (co-IP) has proven effective. Based on published methodologies:

• Sample preparation:

  • For native interactions: Use detergent-solubilized mouse brain extracts

  • For exogenous interactions: Use COS7 cells co-transfected with DPP6 and potential interacting proteins

  • Lysis buffer: 150 mM NaCl, 20 mM Tris-HCl, 1% NP40, 0.5% SDS with protease inhibitor mixture

• Immunoprecipitation protocol:

  • Add anti-DPP6 antibody (2 μg per 500 μg protein) to lysate

  • Include IgG controls to assess non-specific binding

  • Incubate overnight at 4°C with rotation

  • Immobilize antibody-antigen complex using protein A beads (50 μl)

  • Incubate for 2 hours at room temperature

  • Wash 6 times with lysis buffer

  • Resuspend in reducing SDS sample buffer

• Detection of interacting proteins:

  • Separate proteins on 3-8% Tris-acetate SDS polyacrylamide gels

  • Immunoblot using antibodies against DPP6 (1:2000) and the target interacting protein

  • Visualize using fluorescent secondary antibodies

This approach has successfully identified interactions between DPP6 and Myosin-X, a molecular motor that functions in filopodia formation, as well as interactions with ECM proteins like fibronectin .

How do I design experiments to distinguish DPP6's structural role from its ion channel modulatory function?

Designing experiments to distinguish between DPP6's structural role and its ion channel modulatory function requires careful experimental controls:

• Comparative analysis of DPP6-KO vs. Kv4.2-KO models:

  • Examine dendritic morphology in both knockout models

  • If defects appear in DPP6-KO but not in Kv4.2-KO neurons, this suggests a Kv4.2-independent role for DPP6

  • Research has shown that filopodia deficits in DPP6-KO neurons are not replicated in Kv4.2-KO neurons, demonstrating a specific structural role for DPP6 independent of its function as a Kv4.2 auxiliary subunit

• Structure-function analysis:

  • Create DPP6 mutants that specifically disrupt either:
    a) Interaction with Kv4.2 channels
    b) Interactions with structural proteins (e.g., Myosin-X)

  • Express these mutants in DPP6-KO neurons and assess rescue of morphological vs. electrophysiological phenotypes

• Domain-specific antibodies:

  • Use antibodies that target different domains of DPP6 to block specific interactions

  • Monitor effects on both channel function and structural development

These approaches can help delineate the dual roles of DPP6 in neuronal development and function.

Why might I observe multiple bands when using DPP6 antibody in Western Blot?

Multiple bands in Western blot using DPP6 antibodies could occur for several reasons that require careful interpretation:

• Multiple isoforms: DPP6 has several splice variants that may appear at different molecular weights. The predicted molecular weights for DPP6 are 155 kDa and 98 kDa , with observed weight typically around 98-100 kDa .

• Post-translational modifications: DPP6 may undergo glycosylation or other modifications that alter its apparent molecular weight.

• Proteolytic processing: DPP6 might undergo proteolytic cleavage in certain tissues or conditions, generating fragments detected by the antibody.

• Cross-reactivity: Some antibodies may cross-react with related proteins such as other DPP family members.

• Sample preparation issues: Incomplete denaturation or protein degradation during sample preparation can result in anomalous bands.

To address these issues:

• Compare your results with the expected band pattern reported in the antibody datasheet

• Use recombinant DPP6 protein as a positive control to establish the correct band size

• Consider using tissue from DPP6-KO animals as a negative control to verify antibody specificity

• Test different sample preparation methods to minimize degradation

What controls should I include when validating DPP6 antibodies for my experimental system?

Proper validation of DPP6 antibodies requires rigorous controls:

For immunocytochemistry experiments examining DPP6's role in filopodia formation, researchers have used DPP6-KO neurons treated with either siDPP6 or control siRNA as specificity controls. These experiments confirmed that siDPP6 had no effect on filopodia number in neurons already lacking DPP6, validating both the knockout model and the siRNA specificity .

How do I interpret contradictory results between functional and morphological studies of DPP6?

When faced with contradictory results between functional and morphological studies of DPP6, consider these analytical approaches:

• Temporal dynamics: DPP6 may play different roles at different developmental stages. Early effects might be primarily structural (filopodia formation), while later effects might be more functional (channel modulation). Live imaging experiments have shown both immediate effects on filopodia stability and longer-term consequences for synapse development .

• Cell-type specificity: DPP6 expression and function may vary across different neuronal populations. Ensure you're comparing results from the same cell types.

• Compensatory mechanisms: In knockout or knockdown models, compensatory expression of related proteins may mask certain phenotypes while leaving others intact.

• Methodological differences: Different antibodies target different epitopes and may detect distinct pools of DPP6. Technical variables in fixation, permeabilization, and detection can significantly impact results.

• Regional interactions: Consider that DPP6's multiple binding partners (Kv4.2, Myosin-X, ECM proteins) may have varying levels of expression or availability in different subcellular compartments.

To resolve contradictions, consider combining approaches: perform electrophysiological recordings and morphological analyses on the same neurons, or conduct time-course studies that track both structural and functional changes simultaneously.

How can DPP6 antibodies be used to investigate its potential role in neurological disorders?

DPP6 has been genetically linked to several neurological disorders, and antibody-based approaches offer valuable tools for investigating these associations:

• Autism spectrum disorders: DPP6 has been associated with autism susceptibility. Researchers can use DPP6 antibodies to:

  • Compare expression levels and localization patterns in post-mortem brain tissue from individuals with autism versus controls

  • Examine the impact of autism-associated DPP6 variants on protein localization and interaction networks

  • Study dendritic morphology in neurons derived from patient iPSCs

• Neurodevelopmental disorders: Given DPP6's role in dendritic filopodia formation and stability, researchers should investigate:

  • Whether DPP6 expression patterns are altered in developmental disorders

  • How disruptions in DPP6 expression affect critical periods of synaptogenesis

  • The relationship between DPP6-mediated structural abnormalities and functional deficits

• Renal function and toxicology: Recent research suggests DPP6 variants may mediate between aluminum in plasma and renal function . Antibody-based approaches could be used to:

  • Localize DPP6 in kidney tissue

  • Investigate the molecular pathway connecting DPP6, metal toxicity, and renal function

  • Study potential protective mechanisms against aluminum toxicity

These studies would benefit from combining immunohistochemistry, biochemical assays, and functional approaches to build a comprehensive understanding of how DPP6 variants contribute to disease pathology.

What methodologies are recommended for studying developmental versus mature neuron expression of DPP6?

Studying DPP6 expression and function across neuronal development requires specialized approaches:

• Developmental time-course studies:

  • Collect brain tissue or culture neurons at different developmental stages (e.g., DIV3, DIV7, DIV14, DIV21)

  • Use Western blot to quantify total DPP6 protein expression changes

  • Perform immunocytochemistry to track changes in subcellular localization

  • Research has shown progressive decrease in dendritic filopodia between DIV7 and DIV21, with corresponding increases in spine and synapse density during maturation

• Subcellular localization analysis:

  • Co-immunostain for DPP6 along with:

    • MAP2 (dendritic marker)

    • Tau-1 (axonal marker)

    • Phalloidin (actin-based structures)

    • PSD-95 (postsynaptic density)

    • Synaptophysin (presynaptic marker)

  • This approach can reveal developmental shifts in DPP6 localization from filopodia to mature synapses

• Functional correlation:

  • Combine morphological analyses with electrophysiological recordings at different developmental stages

  • Determine how DPP6's structural role in early development relates to its later channel modulatory functions

• Super-resolution microscopy:

  • Use techniques like STORM or PALM with DPP6 antibodies to track nanoscale changes in protein clustering during development

  • Combine with multicolor imaging to visualize interactions with different partners at different stages

These approaches can help elucidate how DPP6's diverse functions are coordinated throughout neuronal development.

How can I investigate the relationship between DPP6 genomic variants and protein function?

Several DPP6 genomic variants have been identified in genome-wide association studies, including intron variants at suggestive levels of significance . To investigate their functional impact:

• Expression analysis:

  • Use antibodies to compare DPP6 protein levels in samples with different genotypes

  • Perform RT-PCR to determine if intronic variants affect mRNA splicing or expression levels

  • Investigate tissue-specific expression differences that might explain variant effects

• Functional characterization:

  • Generate cell lines or animal models expressing specific DPP6 variants

  • Use co-immunoprecipitation to assess whether variants alter protein-protein interactions

  • Perform electrophysiological recordings to determine effects on channel function

• Structural studies:

  • For missense variants, investigate effects on protein folding, stability, and trafficking

  • For intronic variants, examine potential effects on regulatory elements using reporter assays

• Mediator analysis:

  • Investigate DPP6's potential role as a mediator between environmental factors (e.g., aluminum exposure) and physiological outcomes like renal function

  • Design experiments to test whether specific variants enhance or diminish this mediator role

This comprehensive approach can help translate genetic associations into mechanistic understanding of how DPP6 variants contribute to physiological differences or disease risk.